Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP19A1 | P11511 | 3/20 | 0.56 |
| ▸ | PKM | P14618 | 6/20 | 0.45 |
| ▸ | TAS2R46 | P59540 | 2/20 | 0.45 |
| ▸ | MEN1 | O00255 | 2/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.45 |
| ▸ | RECQL | P46063 | 1/20 | 0.45 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.45 |
| ▸ | TERT | O14746 | 1/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.43 |
| ▸ | LMNA | P02545 | 3/20 | 0.43 |
| ▸ | TP53 | P04637 | 3/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.43 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.43 |
| ▸ | STAT6 | P42226 | 2/20 | 0.43 |
| ▸ | MAPT | P10636 | 2/20 | 0.43 |
| ▸ | NLRP3 | Q96P20 | 2/20 | 0.43 |
| ▸ | CASP1 | P29466 | 1/20 | 0.43 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.43 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Dehydrocostuslactone SCHEMBL936050 | 0.79 | CYP19A1 (0.46) | CYP19A1PKMTAS2R46MEN1KMT2A | |
| Dehydrocostuslactone SCHEMBL699070 | 0.79 | CYP19A1 (0.46) | CYP19A1PKMTAS2R46MEN1KMT2A | |
| Dehydrocostuslactone SCHEMBL31029489 | 0.79 | CYP19A1 (0.46) | CYP19A1PKMTAS2R46MEN1KMT2A | |
| SCHEMBL30634018 | 0.72 | CYP19A1 (0.47) | CYP19A1PKMTAS2R46MEN1KMT2A | |
| SCHEMBL24453722 | 0.70 | CYP19A1 (0.61) | CYP19A1PKMTAS2R46MEN1KMT2A | |
| Dehydrozaluzanin C SCHEMBL17214360 | 0.68 | CYP19A1 (0.42) | CYP19A1PKMTAS2R46MEN1KMT2A | |
| SCHEMBL24453868 | 0.66 | CYP19A1 (0.52) | CYP19A1PKMTAS2R46MEN1KMT2A | |
| SCHEMBL30471322 | 0.66 | CYP19A1 (0.61) | CYP19A1PKMTAS2R46MEN1KMT2A | |
| SCHEMBL14648703 | 0.65 | PKM (0.52) | CYP19A1PKMTAS2R46MEN1KMT2A | |
| SCHEMBL11891062 | 0.65 | PKM (0.52) | CYP19A1PKMTAS2R46MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4408435-B1 | COMPOSITION COMPRISING HESPERIDIN, CITRAL AND SODIUM ALGINATE AS A FILM-FORMING SUBSTANCE FOR PROPHYLAXIS OF INFECTIONS | MVS PHARMA GMBH (DE) | 2025-08-13 | — | — | EP | disclosed |
| CN-119438438-A | Quality detection method of antiviral particles | 成都中医药大学 | 2025-02-14 | — | — | CN | disclosed |
| EP-4408435-A1 | COMPOSITION COMPRISING HESPERIDIN, CITRAL AND A FILM-FORMING SUBSTANCE FOR PROPHYLAXIS OF INFECTIONS | MVS Pharma GmbH (DE) | 2024-08-07 | — | — | EP | disclosed |
| US-20230310343-A1 | Method of Plant-Based Inhalation for the Treatment of Respiratory Viruses | WEBB YVETTE ROSE (CA) | 2023-10-05 | — | — | US | disclosed |
| US-20230285485-A1 | OPTIMIZING VOLATILE ENTOURAGES IN DRY FLOWERING PLANT MIXTURES | Perfect Herbal Blends, Inc. | 2023-09-14 | — | — | US | disclosed |
| US-11654170-B2 | Optimizing volatile entourages in dry flowering plant mixtures | Perfect Herbal Blends, Inc. (US) | 2023-05-23 | — | — | US | disclosed |
| US-11638733-B2 | Optimizing volatile entourages in dry flowering plant mixtures | Perfect Herbal Blends, Inc. (US) | 2023-05-02 | — | — | US | disclosed |
| WO-2023052310-A1 | COMPOSITION COMPRISING HESPERIDIN, CITRAL AND A FILM-FORMING SUBSTANCE FOR PROPHYLAXIS OF INFECTIONS | MSV PHARMA GMBH (DE) | 2023-04-06 | — | — | WO | disclosed |
| EP-4159208-A1 | COMPOSITIONS AND METHODS FOR THE PROPHYLAXIS OF AN INFECTION | MVS Pharma GmbH (DE) | 2023-04-05 | — | — | EP | disclosed |
| US-20220110991-A1 | OPTIMIZING VOLATILE ENTOURAGES IN DRY FLOWERING PLANT MIXTURES | Perfect Herbal Blends, Inc. | 2022-04-14 | — | — | US | disclosed |
| US-20220110990-A1 | OPTIMIZING VOLATILE ENTOURAGES IN DRY FLOWERING PLANT MIXTURES | Perfect Herbal Blends, Inc. | 2022-04-14 | — | — | US | disclosed |
| WO-2022049420-A1 | METHOD OF PLANT-BASED INHALATION FOR THE TREATMENT OF RESPIRATORY VIRUSES | WEBB, Clive, Alan (CA) | 2022-03-10 | — | — | WO | disclosed |
| US-11253564-B2 | Optimizing volatile entourages in dry flowering plant mixtures | Perfect Herbal Blends, Inc. (US) | 2022-02-22 | — | — | US | disclosed |
| CN-111454267-A | Coriander soda nail and preparation method and application thereof | 中国科学院昆明植物研究所 | 2020-07-28 | — | — | CN | disclosed |
| US-10195216-B1 | Antimicrobial activity and oil compositions of Costus speciosus (KOEN) | KING ABDULAZIZ UNIVERSITY (SA) | 2019-02-05 | — | — | US | disclosed |
| CN-107782801-A | A kind of Chinese ephedra and the chemical composition supercritical extraction method of Herba ephedrae | 杨恩许 | 2018-03-09 | — | — | CN | disclosed |
| EP-0453920-B1 | Method for the purification of alpha-bisabolol | BASF AG (DE) | 1993-12-08 | — | — | EP | disclosed |
| EP-0453920-A1 | Method for the purification of alpha-bisabolol | BASF Aktiengesellschaft (DE) | 1991-10-30 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10195216-B1 | Antimicrobial activity and oil compositions of Costus speciosus (KOEN) | CUTA, PTGES, FASN | CYP19A1 950/4885PKM 3940/4885TAS2R46 2119/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.